Gilead Sciences
VerifiedBiopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$98.9b (Public information from May 2024)
Share price
€68.88 GILD.MI
Foster City California (HQ)
Deals in current and previous year:
Authorizing premium user...